APEX BIOTECH said unconsolidated sales in February rose 41.70% to NT$180,903,000 from NT$127,667,000, according to a statement filed to the Taiwan Stock Exchange.

(Figures are in thousands of New Taiwan dollars)


2/2012 2/2011 Sales 180,903 127,667 YOY% 41.70%

-----------------Year-to-date----------------- Sales 333,233 226,129 YOY% 47.36% =================================================================

Before it's here, it's on the Bloomberg Terminal. LEARN MORE